top of page

Publications

Communicating Evidence

Year
Title
Authors
Journal / Meeting
2014
Improving Access to Shared Decision Making for Latin Americans with Inadequately Controlled Type 2 Diabetes Mellitus
Davidson J, Allende-Vigo M, Aguilar R, Bailey R, Martin S, Shillington AC
AACE 23rd Annual Scientific and Clinical Congress
2014
Shared Decision-Making and a Patient Decision Aid for Inadequately Controlled Type 2 Diabetes Mellitus
Shillington AC, Col N, Bailey RA, Martin S
American Association of Diabetes Educators Annual Meeting
2014
The AbobotulinumtoxinA Economic Evaluation Program (DEEP): A Cost Analysis Of Cervical Dystonia (CD) Treatment Switch From OnabotulinumtoxinA (Botulinum Toxin A [ONA]) To AbobotulinumtoxinA ([ABO])
Trosch RM, English ML, Shillington AC, Marchese D
Movement Disorders
2014
Cultural Adaptation of a Patient Decision Aid for Inadequately Controlled Type 2 Diabetes Mellitus in Latinos
Aguilar R, Davidson J, Allende-Vigo M, Bailey R, Shillington A
National Hispanic Medical Association Meeting 18th Annual Conference
2014
Systematic review of measures of personal recovery used in schizophrenia
Shillington A, Benson C, Frye C
Value in Health
2013
Prevalence of Axial SpA in US Rheumatology Practices: Assessment of ASAS Criteria vs Rheumatology Expert Clinical Diagnosis
Strand V, Rao SA, Shillington AC, Cifaldi MA, McGuire M, Ruderman EM
Arthritis Care Res
2013
Costs Associated with Intravenous Patient Controlled Analgesia (IV PCA) in US Hospitals
Schechter LN, Harshaw Q, Ernst FR, Krukas MR, Shillington AC
ISPOR 18th Annual International Meeting
2013
Middle-of-the-night hypnotic use in a large national health plan
Roth T, Berglund P, Shahly V, Shillington AC, Stephenson JJ, Kessler RC
J Clin Sleep Med
2013
Composite International Diagnostic Interview Screening Scales for DSM-IV Anxiety and Mood Disorders
Kessler RC, Calabrese JR, Farley PA, Gruber MJ, Jewell MA, Katon W, Keck PE, Nierenberg AA, Sampson NA, Shear MK, Shillington AS, Stein MB, Thase ME, Wittchen HU
Psychol Med
2012
Costs Associated with Breakthrough Pain in Cancer Patients
Narayana A, Katz N, Shillington AC, Stephenson JJ, Frye C, White RE, Portenoy R
American Academy of Pain Management
2012
Effect of Breakthrough Pain on Functional Status, Pain Interference, and Disability in Cancer Patients: Findings from the National Breakthrough Pain Survey
Narayana A, Katz N, Shillington AC, Stephenson JJ, Frye C, Portenoy R
American Society of Clinical Oncology Annual Meeting
2012
Prevalence Estimates of Axial Spondyloarthritis Among Patients in German Rheumatology Practices
Rao S, Cifaldi M, Joshi AD, Shillington A, McGuire M, Wittig B, Rudwaleit M
Ann Rheum Dis
2012
Prevalence Estimate and Gender Distribution of Axial Spondyloarthritis Among Patients in US Rheumatology Practices
Rao S, Shillington AC, Strand V, McGuire M, Cifaldi MA
Annual European Congress of Rheumatology
2012
The Associations of Insomnia with Costly Workplace Accidents and Errors: Results from the America Insomnia Survey
Shahly V, Berglund PA, Coulouvrat C, Fitzgerald T, Hajak G, Roth T, Shillington AC, Stephenson JJ, Walsh JK, Kessler RC
Arch Gen Psychiatry
2012
Current Practices in the Management of Chronic Myeloid Leukemia
Kantarjian HK, Larson, RA, Cortes JE, Deering KL, Mauro MJ
Clin Lymphoma Myeloma Leuk
2012
Validation of a Tool to Assess Medication Treatment Satisfaction in Patients with Type 2 Diabetes: the Diabetes Medication System Rating Questionnaire (DMSRQ)
Peyrot M, Harshaw Q, Shillington AC, Xu Y, Rubin RR
Diabet Med
2012
Costs Associated With Breakthrough Pain in Cancer Patients: Findings From the National Breakthrough Pain Survey
Narayana A, Katz N, Shillington AC, Stephenson JJ, Frye C, Portenoy R
ISPOR 18th Annual International Meeting
2012
Bleeding-associated Outcomes with Preoperative Clopidogrel Use in On- and Off-pump Coronary Artery Bypass
Berger, JS, Herout PM, Harshaw Q, Steinhubl SR, Frye CB, Becker RC
J Thromb Thrombolysis
2012
The National Breakthrough Pain Survey: Multivariate Predictors of Functional Status, Pain Interference, and Disability
Narayana A, Katz N, Shillington A, Stephenson J, Portenoy R
PAINWeek
2012
The Cost Associated with Breakthrough Pain: Findings from the National Breakthrough Pain Survey
Narayana A, Katz N, Shillington A, Stephenson J, Portenoy R
PAINWeek
2012
Breakthrough Pain and Its Association with Functional Status, Pain Interference, and Disability in Cancer Patients: Findings from the National Breakthrough Pain Study
Narayana A, Katz N, Shillington AC, Stephenson JJ, Frye C, White RE, Portenoy R
PAINWeek
2012
Insomnia, comorbidity, and risk of injury among insured Americans: results from the America Insomnia Survey
Kessler RC, Berglund PA, Coulouvrat C, Fitzgerald T, Hajak G, Roth T, Shahly V, Shillington AC, Stephenson JJ, Walsh JK
Sleep
2012
Insomnia, Cormorbidity, and Risk of Injury Among Insured Americans: Results from the America Insomnia Survey
Kessler RC, Berglund PA, Coulouvrat C, Fitzgerald T, Hajak G, Roth T, Shahly V, Shillington AC, Stephenson JJ, Walsh JK
Sleep Health and Safety
2012
The Associations of Insomnia with Costly Workplace Accidents and Errors: Results from the American Insomnia Survey
Shahly V, Berglund PA, Coulouvrat C, Fitzgerald T, Hajak G, Roth T, Shillington AC, Stephenson JJ, Walsh JK, Kessler RC
Sleep Health and Safety
2011
Implementation of a Web-Based Patient-Reported Outcomes Research Program
Costello K, Foley J, Miller D, Deering K
American Academy of Neurology
2011
Days-out-of-role associated with insomnia and comorbid conditions in the America Insomnia Survey
Hajak G, Petukhova M, Lakoma M, Coulouvrat C, Roth T, Sampson N, Shahly V, Shillington A, Stephenson J, Walsh J, Kessler RC
Biol Psychiatry
2011
Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey
Roth T, Coulouvrat C, Hajak G, Lakoma MD, Sampson NA, Shahly V, Shillington AC, Stephenson JJ, Walsh JK, Kessler RC
Biol Psychiatry
2011
Creation of a Web-Based Multiple Sclerosis Patient-Reported Outcomes Research Program
Deering K, Agarwal S, Rajagopalan K, Harshaw Q, Shillington A, and the My MS Health Steering Committee
Value in Health
2010
Impact of Worsening Renal Function During Hospital Admission on Resource Utilization in Patients With Heart Failure
Herout P, Harshaw Q, Phatak H, Saka G, McNeill A, Wu D, Sazonov V, DeSagun R, Shirani J
Am J Cardiol
2010
Structure and Diagnosis of Adult Attention-Deficit/Hyperactivity Disorder: Analysis of Expanded Symptom Criteria from the Adult ADHD Clinical Diagnostic Scale
Kessler RC, Green JG, Adler LA, Barkley RA, Chatterji S, Faraone SV, Finkelman M, Greenhill LL, Gruber MJ, Jewell M, Russo LJ, Sampson NA, Van Brunt DL
Arch Gen Psychiatry
2010
Concordance of computerized self-report measures of DSM-IV-Tr, mood and anxiety disorders compared to gold standard clinical assessments in primary care
Kessker R, Farley A, Jewell M
ISPOR 15th Annual International Meeting
2010
Concordance of self-report measures of DSM-IV-TR, ICD-10, and RDC insomnia with standardized clinical assessments in the American Insomnia Survey (AIS)
Kessler R, Hajak G, Lakoma M
ISPOR 15th Annual International Meeting
2010
The American Insomnia Survey: an epidemiology study of insomnia prevalence and burden in a representative population
Kessler R, Coulouvrat C, Hajak G
ISPOR 15th Annual International Meeting
2010
Consensus and Discordance in the Management of Growth Hormone-Treated Patients: Results of a Knowledge, Attitudes, Beliefs, and Practices Survey
Miller BS, Shulman DI, Shillington A
Int J Pediatr Endocrinol
2010
The National Breakthrough Pain Survey (NBTPS): Design, Methodology, and Interim Results
Narayana A, Katz N, Shillington A
International Association for the Study of Pain 13th World Congress on Pain
2010
Dialysis health outcomes associated with pre-dialysis use of paricalcitol compared with no vitamin D receptor (VDR) activator treatment
Marx S, Frye C, Khan S
National Kidney Foundation
2010
Paricalcitol treatment in CKD patients with secondary hyperparathyroidism is associated with better health outcomes when compared with no vitamin D receptor [VDR] activator treatment
Sterz R, Frye C, Harshaw Q
National Kidney Foundation
2010
Comparative Effectiveness of Paricalcitol Versus Calcitriol Treatment in Chronic Kidney Disease [CKD] Patients with Secondary Hyperparathyroidism [SHPT]
Marx S, Frye C, Khan S, Harshaw Q, Audhya P, Deering K, Sterz R
National Kidney Foundation Spring Clinical Meeting Poster Presentation
2010
Reliability and Validity of the Brief Insomnia Questionnaire (BIQ) in the America Insomnia Survey (AIS)
Kessler R, Coulouvrat C, Hajak G, Lakoma MD, Roth T, Sampson N, Shahly V, Shillington A, Stephenson JJ, Walsh J, Zammit GK
Sleep
2010
Improved Resource Utilization Outcomes Associated with Predialysis Use of Paricalcitol for Secondary Hyperparathyroidism (SHPT)
Marx S, Frye C, Khan S, Harshaw Q, Audhya P, Deering K, Sterz R
Value in Health
2009
The American Insomnia Survey: an epidemiology study of insomnia in subjects with various comorbidities and/or conditions
Kessler RC, Coulouvrat C, Hajak G, Roth T, Sampson N, Shillington AC, Stephenson JJ, Walsh J
3rd International Congress on Sleep Medicine of the World Association of Sleep Medicine and the 12th Brazilian Congress on Sleep Medicine
2009
All-Cause and Cardiovascular-Related Healthcare Resource Utilization and Costs Associated with Paricalcitol Use in Pre-Dialysis Chronic Kidney Disease (CKD) Patients with Secondary Hyperparathyroidism (SHPT) Compared with No Vitamin D Receptor Activator (VDRA) Therapy
Marx SE, Frye CB, Andress DL, Harshaw Q, Sterz R, Deering K, Audhya P
American Society of Nephrology's Renal Week
2009
Evaluation of Pre-Dialysis Doxercalciferol Use on Health Outcomes and Costs Compared to No Vitamin D Receptor Activator (VDRA) Treatment for Secondary Hyperparathyroidism (SHPT)
Harshaw Q, Andress DL, Marx SE, Frye CB, Sterz R, Deering K, Audhya P
American Society of Nephrology's Renal Week
2009
Impact of Pre-Dialysis Use of Calcitriol on Healthcare Resources Utilization and Costs Compared with No Vitamin D Receptor Activator (VDRA) Treatment for Secondary Hyperparathyroidism (SHPT)
Frye CB, Andress DL, Marx SE, Harshaw Q, Sterz R, Deering K, Audhya P
American Society of Nephrology's Renal Week
2009
Poorly Controlled Asthma and Health Service Utilization in New York in a Medicaid Managed Care Population
Silverman R, Reibman J, and the New York State Asthma Control and Co-morbidities Working Group
American Thoracic Society
2009
Discrepancies Between Knowledge, Attitudes and Beliefs and the Actual Practice (KABP) of Physicians who Care for Patients with Depression and/or Bipolar Disorder
Jewell M, Keck P, Golden WE, Brewster C, Farley AP, Harshaw Q
ISPOR 14th Annual International Meetin
2009
A Conceptual Analysis of the Costs of Care for a ?Major Bleed? in Studies of Antiplatelet and Antithrombotic Therapies
Harshaw Q, Frye CB, Hauch O
ISPOR 14th Annual International Meeting
2009
Improving data entry for post-marketing surveillance rhGH databases: Lessons from a knowledge (K), attitudes (A), beliefs (B) and practices (P) survey of Pediatric Endocrinologists
Kennedy J, Shulman D, Shillington A, Harshaw Q, Colgan K, Schwartz D, Kappy M, Wyatt D, Miller BS, Wilson D, McCormack L, Bakker B, Lippe B
Pediatric Endocrinology Nursing Society
2009
Comparing Outcomes Associated With Dose Manipulations of Enteric-Coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Renal Transplant Recipients?
Cooper M, Deering KL, Slakey DP, Harshaw Q, Arcona S, McCann EL, Rasetto FA, Florman SS
Transplantation
2008
Switching HIV-infected, suppressed patients from ABC/3TC to FTC/TDF improves lipids - the SETTLE study
Gathe JC
10th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV
2008
The STAndards for BipoLar Excellence (STABLE) Project: A bipolar disease quality improvement initiative to develop and validate evidence-based performance measures for national endorsement
Jewell MA, Golden W, Keck P
13th Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research
2008
Single Agent Therapy with Lopinavir/Ritonavir Suppresses HIV-1 Viral Replication in ARV Na?ve Patients: IMANI II ? 96 Week Final Results
Gathe JC, Yeh RF, Mayberry C, Nemecek J, Miguel B, Lipman BA, Fath MJ
48th Annual ICAAC / IDSA 46th Annual Meeting
2008
Pharmacoeconomic analysis of bleeding complications and reoperation costs in patients with ACS receiving clopidogrel who require CABG surgery
Harshaw Q, Wygant GD, Hauch O, Berger JS, Frye CB, Becker RC
AHA 9th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke
2008
Impact of thienopyridines on bleeding complications with ACS patients requiring CABG surgery
Berger JS, Frye CB, Harshaw Q, Edwards FH, Steinhubl SR, Becker RC
American Heart Association Scientific Sessions
2008
Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis
Berger JS, Frye CB, Harshaw Q, Edwards FH, Steinhubl SR, Becker RC
J Am Coll Cardiol
2008
Psychosocial Interventions as Adjunctive Therapy for Bipolar Disorder
Sachs GS
J Psychiatr Prac
2008
Collaborative Mental Health and Primary Care for Bipolar Disorder
Williams JW, Manning JS
J Psychiatr Pract
2008
Clinical and Economic Effects of Unrecognized or Inadequately Treated Bipolar Disorder
Keck PE, Kessler RC, Ross R
J Psychiatr Pract
2008
Development of Evidence-Based Performance Measures for Bipolar Disorder: Overview of Methodology
Golden WE, Hermann RC, Jewell M, Brewster C
J Psychiatr Pract
2008
The STABLE Project: Addressing the Gap Between Evidence and Practice for Bipolar Disorder
Golden WE, Keck PE, Sachs GS, Oldham JM, Brewster C, Ross R
J Psychiatr Pract
2008
The Recovery Concept: Clinician and Consumer Perspectives
Stotland NL, Mattson MG, Bergeson S
J Psychiatr Pract
2008
Overview of the STAndards for BipoLar Excellence (STABLE) Project
Brewster C
J Psychiatr Pract
2008
Quality Improvement in Psychiatry: Why Measures Matter
Oldham JM, Golden WE, Rosof BM
J Psychiatr Pract
2008
Consensus and discordance in treating recombinant human growth hormone (rhGH) treated patients: results of a knowledge (K), attitudes (A), beliefs (B) and practices (P) [KABP] survey
Miller BS, Shulman D, Shillington AC
Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting
2008
Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting
Pickard AS, Becker RC, Schumock GT, Frye CB
Pharmacotherapy
2007
Single agent therapy with lopinavir/ritonavir controls HIV-1 replication in the central nervous system
Yeh RF, Letendre S, Novak IS
14th Conference on Retroviruses and Opportunistic Infections
2007
A comparison of adverse events and quality of life before and after switching from Kaletra? Soft-gel to Kaletra? Tablets in an African American cohort
Rawlings MK, McGhee TA, Casey-Bailey S, Pasley M
2007 American Conference for the Treatment of HIV
2007
Performance indicators for bipolar disorder: development and feasibility testing
Williams JW, Golden W, Keck PE, Jewel M, Brewster C
30th Annual Meeting of the Society of General Internal Medicine
2007
Linear growth and BMI during growth hormone treatment of children with craniopharyngioma compared to other organic growth hormone deficiencies: The National Cooperative Growth Study experience
Lustig R, Meacham L, Frane J, Frye C, Bakker B
46th Annual Meeting of the European Society for Paediatric Endocrinology
2007
Single-agent Therapy with Lopinavir/ritonavir Suppresses Plasma HIV-1 Viral Replication in HIV-1 Na?ve Subjects: IMANI-2 48-Week Results
Gathe JC, Yeh RF, Mayberry C
4th IAS Conference
2007
Success of a Comprehensive school-based asthma intervention on clinical markers and resource utilization for inner-city children with asthma in Chicago: the Mobile CARE Foundation's asthma management program
Patel B, Sheridan P, Detjen P
Journal of Asthma
2006
Tolerability and therapy preference of lopinavir/ritonavir (Kaletra) Soft-gel capsules and tablets as single agent in a cohort of HIV positive adult patients (IMANI-2)
Gathe JC, Lipman BA, Mayberry C, Miguel B, Nemecek J
8th International Congress on Drug Therapy in HIV Infection
2005
Outbreak of catheter-associated Klebsiella oxytoca and Enterobacter cloacae bloodstream infections in an oncology chemotherapy center
Watson JT, Jones RC, Siston AM, Fernandez JR, Martin K, Beck E, Sokalski S, Jensen BJ, Arduino MJ, Srinivasan A, Gerber SI
Archives of Internal Medicin
2005
Antithrombotic therapy practices in US hospitals in an era of practice guidelines
Tapson VF, Hyers TM, Waldo AL
Archives of Internal Medicine
2005
Retrospective cohort study of granisetron administration for PONV prophylaxis and treatment
Shillington AC, Farley PA, Varkey JA, Dempsey C, Murdakes C
Hospital Pharmacy
2005
Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs
Caprini JA, Tapson VF, Hyers TM
Journal of Vascular Surgery
2005
Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation
Waldo AL, Becker RC, Tapson VF, Colgan KJ
Journal of the American College of Cardiology
2004
Oral capecitabine plus radiation therapy administered neoadjuvantly in the management of rectal cancer
Sharif A, Ajlouni M, Wollner I
86th Annual Meeting of the American Radium Society
2004
The Long-term Outcomes of Sibutramine Effectiveness on Weight (LOSE Weight) Study: evaluating the role of drug therapy within a weight management program in a group-model health maintenance organization
Porter JA, Raebel MA, Conner DA
Am J Manag Care
2004
Disparities in antithrombotic management
Caprini JA, Ballard DJ, Becker RC
American Heart Association 5th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke
2004
Antiemetic effectiveness of ondansetron and granisetron in patients with breast cancer treated with cyclophosphamide
Dempsey CL, Coop AJ, Shillington AC, Farley PA, Eberhardt DR, O'Briant S
American Journal of Health-System Pharmacy
2004
Venous thromboembolism treatment: results of a national database
Caprini JA, Marchev D, Glase C
American Venous Forum
2004
The National Anticoagulation Benchmark and Outcomes Report (NABOR?): evidence of a significant difference between guidelines and actual practice
Tapson VF, Hyers TM, Becker RC, Waldo AL, Colgan KJ, Shillington AC
International Society for Pharmacoeconomics and Outcomes Research 9th Annual International Meeting
2004
A comparison of hepatitis C treatment and outcomes at academic, private and Veterans? Affairs treatment centers
Jensen DM, Cotler SJ, Lam H, Harb G, Shillington AC
Journal of Alimentary Pharmacology and Therapeutics
2004
Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy: case report
Rogers LR, Remer SE, Sheela Tejwani S
Neuro-oncology
2003
A multicenter drug utilization evaluation program for Timentin?
Billeter M, Levato J, Waldrep T, Dempsey CL, Farley PA
ASHP Midyear Meeting
2003
Comparison of survival in patients with pulmonary hypertension associated with fenfluramine to patients with primary pulmonary hypertension
Rich S, Shillington AC, McLaughlin V
American Journal of Cardiology
2003
Management of community-acquired pneumonia in one hospital compared with a national benchmark database
Hampton N, Romie A, Clewell L, Hadzima S, Gerdes JM
Hospital Pharmacy
2003
Complete and sustained remission of refractory cervical cancer following a single cycle of capecitabine a case report
Hindenburg AA, Matthews L
International Journal of Gynecological Cancer
2003
Improvements in glycemic control in type 2 diabetes patients switched from sulfonylurea coadministered with metformin to glyburide-metformin tablets
Duckworth W, Marcelli M, Padden M
Journal of Managed Care Pharmacy
2003
Pyridoxine treatment and prevention of hand-and-foot syndrome in patients receiving capecitabine
Mortimer JE, Lauman MK, Tan B, Dempsey CL, Shillington AC, Hutchins KS
Journal of Oncology Pharmacy Practice
2003
5-HT3 antiemetic use in breast cancer patients receiving cyclophosphamide: a multi-center practice evaluation
Coop AJ, Farley PA, Shillington AC, Dempsey CL, Colgan KC
MASCC/ISOO 15th International Symposium
2003
A descriptive practice evaluation of granisetron utilization in the management of postoperative nausea and vomiting
Shillington A, Dempsey C, Farley PA, Coop A, Eberhardt DR, Varkey JA
New York State Society of Anesthesia Annual Meeting
2003
Hormone-refractory prostate cancer responding to capecitabine ?
El-Rayes, BF ,Black CA, Ensley JF
Urology
2002
Improvements in glycemic control in type 2 diabetes patients switched from sulfonylurea co-administered with metformin to glyburide/metformin tablets
Duckworth W, Marcelli M, Roman F
Academy of Managed Care Pharmacy
2002
Prognosis of patients with primary pulmonary hypertension induced by fenfluramine diet pills
Rich S, Shillington A, McLaughlin VV
American Thoracic Society
2002
Survival in primary pulmonary hypertension: the impact of epoprostenol therapy
McLaughlin VV, Shillington A, Rich S
Circulation
2002
A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies
Vaishampayan UN, Ben-Josef E, Philip PA
Int J Radiation Oncology Biology Physics
2002
Granisetron vs dolasetron for acute nausea and vomiting in high and moderately-high emetogenic chemotherapy
Tan M, Xu R, Seth R
MASCC/ISOO 14th International Symposium
2001
Chronic fatigue syndrome (CFS): pharmacoeconomic analysis of Ampligen? intervention
Shillington AC, Hilley H, Carter WA, Strayer DR
AACSF Annual Meeting
bottom of page